All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Secondary Lymphedema | NCIT_C48830 | [A condition that is caused by trauma to the lymph system, which disrupts the normal flow of lymph fluid. This is most often due to surgery that requires lymph node removal or a large amount of lymph tissue. This disruption is especially apparent if the lymph nodes under the arm and arm and around the breast are compromised due to breast cancer surgery, diagnostic dissection, mastectomy, or radiation.] |
| Testing of Raw/Starting Materials | NCIT_C139451 | [The investigation employed relevant empirical testing of the materials used in construction of the device involved in the reported adverse event in order to support the identification of possible causes for the adverse event. Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the latest relevant standards.] |
| Testing of Patient Sample or Reference Material Using Manufacturer's Device | NCIT_C139452 | [The investigation employed relevant empirical testing of a patient sample or reference material using the device (usually an IVD) involved in the reported adverse event in order to support the identification of possible causes for the adverse event. Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the latest relevant standards.] |
| Patient Navigator | NCIT_C48832 | [Persons who are trained to guide and support those requiring assistance obtaining medical care. Such persons are sensitive to socio-economic factors within the community and provide a variety of services. Their primary responsibilities are to assist patients that have an abnormal examination or a positive finding to navigate through the health care system.] |
| Testing of Patient Sample or Reference Material Using Reference Method | NCIT_C139453 | [The investigation employed relevant empirical testing of a patient sample or reference material using an appropriate reference method to the device (usually an IVD) involved in the reported adverse event in order to support the identification of possible causes for the adverse event. Relevant testing would typically be based on test methods used for evaluating safety and performance as described in the latest relevant standards.] |
| Bevonium | NCIT_C73804 | |
| Solifenacin Succinate | NCIT_C73805 | |
| Elzasonan Hydrochloride | NCIT_C73806 | |
| Nitrafudam Hydrochloride | NCIT_C73807 | |
| Tenidap Sodium | NCIT_C73800 | |
| Betoxycaine Hydrochloride | NCIT_C73801 | |
| Tedisamil Sesquifumarate | NCIT_C73802 | |
| Bimosiamose Disodium | NCIT_C73803 | |
| Midgut | NCIT_C34210 | [The middle region (foregut, midgut and hindgut) of the early formation of the digestive tract in the developing embryo, which gives rise to the distal duodenum, jejunum, ileum, cecum, appendix, and colon from the cecum to the distal transverse colon.] |
| Midgut Loop | NCIT_C34211 | [The portion of the midgut in the developing embryo that bends around the superior mesenteric artery to form the alimentary canal from the duodenum through the proximal two-thirds of the transverse colon.] |
| Morula | NCIT_C34212 | [An early stage in embryonic development, that occurs between the zygote and the blastocyst stage during the first week post fertilization, and is characterized by the formation of a solid mass of cells (blastomeres) with a "mulberry" appearance.] |
| Mucous Connective Tissue | NCIT_C34213 | [A gelatinous type of connective tissue that is found in the umbilical cord.] |
| Embryonic Connective Tissue | NCIT_C32504 | [One of two types of loose tissue formed during early embryonic development: mesenchyme and mucoid. Mesenchyme connective tissue eventually forms the supporting tissues of the embryo; mucoid connective tissue is found in the umbilical cord (Wharton's jelly), pulp of developing teeth, and in the nucleus pulposus of intervertebral disks.] |
| Breast Cancer pNX TNM Finding v8 | NCIT_C139429 | [Breast cancer in which regional lymph nodes cannot be assessed (e.g., not removed for pathological study or previously removed). (from AJCC 8th Ed.)] |
| Cutaneous Melanoma pN2 TNM Finding v6 | NCIT_C48859 | [Cutaneous melanoma involving two to three regional lymph nodes, or involving the regional intra-lymphatic system without nodal involvement. (from AJCC 6th Ed.)] |